Click here to view our newsroom page on the Newswise news-distribution service, for more information on our organization and a live stream of our Facebook and Twitter feeds.


Free WCG Foundation webinars offer insights on speeding access to experimental drugs for intermediate-size patient populations

January 9, 2018|Categories: News|

Presenters include Richard Klein, formerly of FDA, and Marjorie Speers of WCGF

ATLANTA, Ga.,  Jan. 9, 2018—WCG Foundation will host free webinars Jan. 25 and Feb. 5 on how to streamline the application process for experimental medications for intermediate-size populations of desperately ill patients.

The webinars—“Intermediate-Size Patient Populations INDs: What Are They, When Should They Be Used, and Who May Apply for Them?”—feature Richard Klein, former director of the Food and Drug […]

Right to Try Bills Push the Needle on Risk’ –  panel of experts, including WCGF Executive Director Marjorie A. Speers, discuss risks associated with Right-to-Try legislation

December 24, 2017|Categories: News|

Published December 24, 2017 by OncLive

“Congressional “right-to-try” legislation could make investigational drugs available to desperately ill patients sooner in the trials process, but there are substantial risks, said a panel of experts at the Patient-Centered Oncology Conference, held November 16-17 in Philadelphia, Pennsylvania.

Earlier in the clinical trials process, less is known about the drugs, which may be highly toxic and may have no efficacy. Furthermore, the House of Representatives’ version […]

Panel of experts, including WCGF Executive Director Marjorie A. Speers, discuss Right to Try bill at Patient Centered Oncology Care 2017 meeting

November 17, 2017|Categories: News|

Published November 17, 2017 by HCA News

“Marjorie A. Speers, Executive Director of the WCG Foundation, also had problems with Right to Try laws. Under the existing system, the process encourages deliberate decisions: first, the patient and their physician decide they want to pursue a drug undergoing clinical trial; then, they request that access from the drug’s maker and the company can decide if they believe the drug will be useful; […]

WCG Foundation receives $50,000 from Johnson & Johnson

November 7, 2017|Categories: News|

PRINCETON, N.J. Nov. 7, 2017—WCG Foundation has received $50,000 from Johnson & Johnson to help desperately ill patients get access to experimental medicines.

The gift supports WCGF’s efforts to help patients navigate the Food and Drug Administration’s expanded access program, which makes investigational drugs available to patients who have exhausted all other treatment and clinical trial options.

Learn More >

WCGF Director David Farber, JD provides expertise in NPR’s 1A Discussion of Expanded Access and Senate Right-To-Try Legislation

August 7, 2017|Categories: News|

David Farber, Partner in the FDA and Life Sciences practice of the law firm King and Spalding, and a Director of WCGF lent his expertise to a nuanced discussion of the questions surrounding expanded access to experimental drugs for patients seeking drugs outside of clinical trials.  The program, which provided multiple views on state Right-To-Try legislation as well as the Senate’s recent passing of federal Right to Try legislation, aired […]

Pfizer Grant Helps WCG Foundation Identify Obstacles to Expanded Access

January 25, 2017|Categories: News|

WCG Foundation Progress Report, January 25, 2017

WCG Foundation (WCGF) has received a $5,000 grant from Pfizer to identify obstacles that could discourage physicians from helping desperately ill patients who want to access investigational drugs.

The grant is the latest to support WCGF’s Expanded Access Project, which helps those who have exhausted all treatment and clinical trial options and want the chance to try experimental medicines. Learn more.


GlaxoSmithKline Grant Supports WCGF Expanded Access Project

January 24, 2017|Categories: News|

WCG Foundation Progress Report, January 24, 2017

WCG Foundation (WCGF) has received $15,000 from GlaxoSmithKline (GSK) for the Foundation’s Expanded Access Project. The project helps desperately ill patients who have exhausted all treatment and clinical trial options and want to try experimental medicines.

WCGF will use the GSK grant to help institutional review boards (IRB) streamline the process that patients must navigate to gain access to investigational drugs and devices. Learn more.

$100,000 Grant from Robert Wood Johnson Foundation Supports WCGF Expanded Access Program

October 31, 2016|Categories: News|

WCG Foundation Progress Report, October 31, 2016

WCG Foundation (WCGF) has received $100,000 from the Robert Wood Johnson Foundation (RWJF) to support WCGF’s new Expanded Access Project. The grant targets physicians and institutional review boards (IRBs), who play key roles in helping desperately ill patients gain access to experimental medicines.

Launched in July, the Expanded Access Project seeks to streamline the process for those seeking Food and Drug Administration (FDA) approval to […]

First WCGF Grant Funds Innovative Research Ethics Curriculum at NYU

August 17, 2016|Categories: News|

WCG Foundation Progress Report, August 17, 2016

WCG Foundation’s (WCGF’s) first grant—a two-year $200,000 award to New York University (NYU)—has already enabled NYU Langone Medical Center (NYULMC) to strengthen research ethics education within and beyond the medical center. During the first year, NYU funded curriculum development and supported faculty participation in lectures, webinars, panel discussions, and other outreach efforts.

As a result, 20 students at NYULMC completed a new course in research […]

Load More Posts